BI 685509
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for BI 685509, covering 2016-05-04 to 2025-04-29. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Test Whether BI 685509 Alone or in Combination With Empagliflozin Helps People With Liver Cirrhosis Caused by Viral Hepatitis or Non-alcoholic Steatohepatitis (NASH) Who Have High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver) [Phase 2]